VanEck Pharmaceutical ETF Rating $115.77 +0.25 (+0.22%) As of 09/3/2026 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOptions ChainOwnershipRatingsShort Interest VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.61Holdings in PPH have an aggregate rating of Moderate Buy based on 353 analyst ratings issued in the past year covering 22 companies (86.2% of the portfolio).PPH Aggregate Price Target$115.77High Prediction$115.77Average Prediction$115.77Low Prediction$115.77Holdings in PPH have an aggregate price target of $115.77 and a range of $115.77 to $115.77 covering 22 companies (86.2% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings19.11%LLYEli Lilly and Company$1,160.98+0.1%4.9262 of 5 stars2.83$1,292.18 11.3%30Trending NewsAnalyst Upgrade10.96%MRKMerck & Co., Inc.$152.32+0.4%4.5164 of 5 stars2.65$147.60 -3.1%23Positive News5.05%PFEPfizer$28.82-0.7%3.8867 of 5 stars2.19$28.28 -1.9%21Trending NewsOptions Volume4.98%BMYBristol Myers Squibb$68.06+0.6%4.7223 of 5 stars2.56$66.06 -2.9%25Trending News4.92%NVONovo Nordisk A/S$47.45+1.5%4.0607 of 5 stars2.16$64.94 36.9%19Gap Up4.70%MCKMcKesson$921.70-0.3%4.6416 of 5 stars2.78$973.44 5.6%18Positive NewsEx-DividendShort Interest Decrease4.48%ABBVAbbVie$260.69-0.4%4.6091 of 5 stars2.88$275.95 5.9%26Trending News4.43%JNJJohnson & Johnson$278.66+1.3%4.5737 of 5 stars2.80$272.83 -2.1%25Trending NewsAnalyst ForecastAnalyst Revision4.13%GSKGSK$50.88+0.9%3.0782 of 5 stars2.10$53.00 4.2%10News CoverageDividend CutGap Up4.06%SNYSanofi$44.33-0.3%3.2532 of 5 stars2.40$49.50 11.7%153.68%CORCencora$336.77+0.1%4.8882 of 5 stars2.81$370.85 10.1%16Positive News3.23%HLNHaleon$9.83-0.8%3.6196 of 5 stars2.5511News CoveragePositive NewsHigh Trading Volume3.17%TEVATeva Pharmaceutical Industries$36.58-2.4%3.8135 of 5 stars2.90$42.22 15.4%10Trending News3.12%TAKTakeda Pharmaceutical$18.71+1.5%1.4426 of 5 stars2.2542.18%ZTSZoetis$76.34+0.2%4.9438 of 5 stars2.32$107.43 40.7%19Positive News1.09%VTRSViatris$16.94-0.9%2.5877 of 5 stars2.57$17.50 3.3%71.06%JAZZJazz Pharmaceuticals$247.57+0.8%3.8465 of 5 stars3.00$285.44 15.3%18Insider Trade0.64%CORTCorcept Therapeutics$112.80+2.1%4.2359 of 5 stars2.50$138.17 22.5%8Insider Trade0.60%AXSMAxsome Therapeutics$208.35-0.7%4.2008 of 5 stars2.91$267.60 28.4%22Insider Trade0.33%ELANElanco Animal Health$24.41-1.1%4.6498 of 5 stars2.77$29.09 19.2%13Positive News0.22%OGNOrganon & Co.$13.78+0.1%1.7514 of 5 stars1.71$11.40 -17.3%70.08%PRGOPerrigo$14.26-1.6%3.6332 of 5 stars2.00$19.33 35.6%6 This page (NASDAQ:PPH) was last updated on 9/4/2026 by MarketBeat.com Staff. From Our PartnersThe 2026 beginners Guide to Gold IRAsGold trades near record highs while silver just topped $81 an ounce for the first time ever. Thousands of A...Goldco Direct, LLC | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredAre you leaving Social Security money on the table?Most retirement plans still have gaps in them... The quiet ones that don't show up until it's too late to fix....Money Pickle | SponsoredHow Long Does $2.5M Last in Retirement?Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredBefore Anthropic becomes impossible to ignore...Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
